FDA Grounds Foshan Flying Medical Products

Drug Industry Daily
A A
The FDA warned a Chinese drugmaker for inadequate testing and quality control for drug supplies and finished products, as well as numerous other GMP violations.

To View This Article:

Login

Subscribe To Drug Industry Daily